Efficacy of Three Artemisinin Combination Therapies for Malaria Treatment
Author Information
Author(s): Ingrid van den Broek, Christa Kitz, Sarwatt Al Attas, François Libama, Manica Balasegaram, Jean-Paul Guthmann
Primary Institution: Médecins sans Frontières, London, UK
Hypothesis
Which artemisinin combination therapy is most effective for treating uncomplicated Plasmodium falciparum malaria in children?
Conclusion
Artemether-lumefantrine (AL) is more effective than artesunate + sulfadoxine-pyrimethamine (AS+SP) and artesunate + amodiaquine (AS+AQ) for treating malaria in the Republic of Congo.
Supporting Evidence
- The cure rate for AL was 100%, while AS+AQ was 98.5% and AS+SP was 90.1%.
- Recurrent parasitaemias were significantly higher in the AS+AQ and AS+SP groups compared to AL.
- No serious adverse events were reported during the study.
Takeaway
This study tested three malaria treatments in kids and found that one treatment worked much better than the others.
Methodology
Children aged 6-59 months were randomized to receive one of three treatments and followed for 28 days to assess treatment success.
Potential Biases
Children treated with AL were slightly older and healthier, which could affect the results.
Limitations
The study's findings may be influenced by the age and health status of children receiving different treatments.
Participant Demographics
Children aged 6-59 months, with a significant proportion under 2 years old.
Statistical Information
P-Value
0.003
Confidence Interval
[95% CI 80.7–95.9]
Statistical Significance
p = 0.003
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website